Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1995
12/14/1995WO1995033495A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
12/14/1995WO1995033493A1 Novel uses of triplex forming oligonucleotides for the treatment of human diseases
12/14/1995WO1995033484A1 Method for treating and preventing atherosclerosis
12/14/1995WO1995033483A1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases
12/14/1995WO1995033482A1 Treatment and prevention of helicobacter infection
12/14/1995WO1995033480A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
12/14/1995WO1995033479A1 Cytotoxic enhancement of tnf with copper
12/14/1995WO1995033478A1 Acylated enol derivatives as prodrugs of elastase inhibitors
12/14/1995WO1995033477A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
12/14/1995WO1995033476A1 A PURIFIED 80 kDa PROTEIN IMPLICATED IN ABDOMINAL AORTIC ANEURYSMS, ANTIBODIES DIRECTED THERETO, AND USES THEREOF
12/14/1995WO1995033475A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
12/14/1995WO1995033474A1 Medicinal composition
12/14/1995WO1995033471A1 Intravasal thrombolysis
12/14/1995WO1995033470A1 Composition for dental use comprising krill enzyme
12/14/1995WO1995033464A2 Retroviral protease inhibitor combinations
12/14/1995WO1995033463A2 Synergistic antibiotic compositions containing a perphyrin and an antibiotic
12/14/1995WO1995033454A1 Uterine fibroid treatment
12/14/1995WO1995030003A3 Morphogenic protein-specific cell surface receptors and uses therefor
12/14/1995WO1995029241A3 Ribozymes with product ejection by strand displacement
12/14/1995WO1995028956A3 Antifibrillatory agent in myocardial reperfusion
12/14/1995WO1995028426A3 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
12/14/1995WO1995027063A3 Rfb retrovirus genome
12/14/1995DE4412794A1 Verfahren zur Herstellung von dendritischen Zellen, so erhaltene Zellen und Behälter zur Durchführung dieses Verfahrens A process for the preparation of dendritic cells thus obtained cells and container for carrying out this method
12/14/1995CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
12/14/1995CA2194302A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy
12/14/1995CA2192468A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
12/14/1995CA2192370A1 Monoclonal antibody active against cd44v6
12/14/1995CA2192332A1 Composition for dental use comprising krill enzyme
12/14/1995CA2192312A1 Helicobacter pylori nickel binding protein
12/14/1995CA2192305A1 Conformationally constrained backbone cyclized peptide analogs
12/14/1995CA2192218A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis
12/14/1995CA2192061A1 Uterine fibroid treatment
12/14/1995CA2191948A1 Retroviral protease inhibitor combinations
12/14/1995CA2191891A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants
12/14/1995CA2191867A1 A purified 80 kda protein implicated in abdominal aortic aneurysms, antibodies directed thereto, and uses thereof
12/14/1995CA2191627A1 Synergistic antibiotic compositions containing a perphyrin and an antibiotic
12/14/1995CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995CA2191104A1 Lag1: a gene for increasing the longevity of eukaryotes
12/14/1995CA2149731A1 Specialized antibody treatment for brain neoplasm
12/13/1995EP0686694A1 Use of azoles as virucidal agents in solutions of biologically active proteins
12/13/1995EP0686642A2 Modified guanidino and amidino thrombin inhibitors
12/13/1995EP0686402A1 Collagen membrane for preventing post-surgical adhesions
12/13/1995EP0686401A2 Living-tissue adhesive and blood coagulant
12/13/1995EP0686397A2 Use of chondroitin sulphate proteoglycans for protection of neurons
12/13/1995EP0686396A1 Enteral composition containing native micellar casein
12/13/1995EP0686395A2 Use of hyaluronic acid for the manufacture of a medicament for the inhibition of platelet aggregation
12/13/1995EP0686260A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
12/13/1995EP0686203A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death
12/13/1995EP0686194A1 Harp family growth factors, preparation methods therefor and uses thereof
12/13/1995EP0686192A1 Method of enhanging fertility
12/13/1995EP0686164A1 Intrinsic inhibitors of aldose reductase
12/13/1995EP0686163A1 Metal-interferon-alpha crystals
12/13/1995EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT
12/13/1995EP0686045A1 Excipient stabilization of polypeptides treated with organic solvents
12/13/1995EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
12/13/1995EP0686040A1 Wound healing composition
12/13/1995CN1113389A High molecular weight desulphatohirudin
12/12/1995US5475106 Agonist for cholecystokinin and gastrin receptors; nervous system, gastrointestinal disorders
12/12/1995US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells
12/12/1995US5475092 Deliver cytotoxic drugs to specific cell population in targeted fashion
12/12/1995US5475091 Monoclonal antibodies produced by a hybridoma cell; antiinflammatory agents
12/12/1995US5475089 Polypeptide produced by cleaving ten amino acid residues from N-terminal end of staphylokinase
12/12/1995US5475088 Stimulant of nerve growth factor
12/12/1995US5475087 Polypeptides
12/12/1995US5475086 Proline-glutamic acid-valine-lysine-glutamic acid-lysine containing oligopeptides or polypeptides; useful or diagnosis or therapy of autoimmune diseases such as insulin-dependent diabetes mellitus
12/12/1995US5475085 Unlimited array of peptides having reverse turn mimetics
12/12/1995US5475052 Collagen-synthetic polymer matrices prepared using a multiple step reaction
12/12/1995US5475027 Retroviral protease inhibitors
12/12/1995US5475013 Inhibit human immunodeficiency virus protease
12/12/1995US5474983 Method of inhibiting pro-inflammatory mediator release from basophils and mast cells
12/12/1995US5474982 PDGF analogs and methods of use
12/12/1995US5474981 Use of the cytokine IP-10 as an anti-tumor agent
12/12/1995US5474980 Prolonged release of biologically active somatotropins
12/12/1995US5474979 Nonirritating emulsions for sensitive tissue
12/12/1995US5474978 Insulin analog formulations
12/12/1995US5474935 Adeno-associated virus (AAV)-based eucaryotic vectors
12/12/1995US5474933 An isolated nucleic acid from gram-negative bacteria SHEWANELLA involved in tyrosine conversion to melanin pigment
12/12/1995US5474928 Arginine deiminase from a Mycoplasma arginini strain
12/12/1995US5474904 Methods of imaging cancer cells using modified C-reactive protein
12/12/1995US5474901 Specifically binds human carboxypeptidase
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995US5474769 Treatment of microbial infection by monocyte stimulation with interleukin-7
12/12/1995US5474766 Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
12/12/1995US5474755 Contacting human tissue with a human monoclonal antibody or antigen binding fragment; detection; identification of tumor cells
12/12/1995CA2005365C Medication for the treatment or prevention of hiv virus infection through passive immunization and processes for its preparation
12/12/1995CA1337731C Inhibitory tetrapeptide of entry into cycle of hemopoietic stem cells, processes for its preparation and its uses
12/11/1995CA2151446A1 Modified satellite rnas and satellite viruses as carriers of adapted ribozymes
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/08/1995CA2151099A1 Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide
12/08/1995CA2148977A1 Methods for the inhibition of platelet adherence and aggregation
12/07/1995WO1995033060A1 Method of cancer treatment by p53 protein control
12/07/1995WO1995033058A1 Gene coding for modified bone morphogenic protein receptor
12/07/1995WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation
12/07/1995WO1995033054A1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
12/07/1995WO1995033053A1 Hepatitis c virus asialoglycoproteins
12/07/1995WO1995033050A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors
12/07/1995WO1995033049A2 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS
12/07/1995WO1995032992A1 Synthetic peptide analogs of lung surfactant protein sp-c
12/07/1995WO1995032991A1 Growth hormone therapy and related methods and pharmaceutical compositions
12/07/1995WO1995032990A1 Cyclodepsipeptide
1 ... 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 ... 3163